[go: up one dir, main page]

IL139708A0 - Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering - Google Patents

Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering

Info

Publication number
IL139708A0
IL139708A0 IL13970800A IL13970800A IL139708A0 IL 139708 A0 IL139708 A0 IL 139708A0 IL 13970800 A IL13970800 A IL 13970800A IL 13970800 A IL13970800 A IL 13970800A IL 139708 A0 IL139708 A0 IL 139708A0
Authority
IL
Israel
Prior art keywords
biological matrices
tissue engineering
decellularizing
acellular
useful
Prior art date
Application number
IL13970800A
Original Assignee
Amiel Gilad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amiel Gilad filed Critical Amiel Gilad
Priority to IL13970800A priority Critical patent/IL139708A0/en
Priority to AU2002224003A priority patent/AU2002224003A1/en
Priority to PCT/IL2001/001060 priority patent/WO2002040630A2/en
Publication of IL139708A0 publication Critical patent/IL139708A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Peptides Or Proteins (AREA)
IL13970800A 2000-11-15 2000-11-15 Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering IL139708A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IL13970800A IL139708A0 (en) 2000-11-15 2000-11-15 Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering
AU2002224003A AU2002224003A1 (en) 2000-11-15 2001-11-15 Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering
PCT/IL2001/001060 WO2002040630A2 (en) 2000-11-15 2001-11-15 Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL13970800A IL139708A0 (en) 2000-11-15 2000-11-15 Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering

Publications (1)

Publication Number Publication Date
IL139708A0 true IL139708A0 (en) 2002-02-10

Family

ID=11074822

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13970800A IL139708A0 (en) 2000-11-15 2000-11-15 Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering

Country Status (3)

Country Link
AU (1) AU2002224003A1 (en)
IL (1) IL139708A0 (en)
WO (1) WO2002040630A2 (en)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4092397B2 (en) * 2002-09-10 2008-05-28 国立循環器病センター総長 Treatment of living tissue for transplantation by applying ultrahigh hydrostatic pressure
US7459154B2 (en) * 2002-12-26 2008-12-02 Cell Genesys, Inc. Methods and reagents for the enhancement of virus transduction in the bladder epithelium
CA2536923C (en) 2003-09-04 2012-10-09 Cook Biotech Incorporated Extracellular matrix composite materials, and manufacture and use thereof
US7592139B2 (en) 2004-09-24 2009-09-22 Sandia National Laboratories High temperature flow-through device for rapid solubilization and analysis
EP1833524B1 (en) * 2005-01-05 2010-07-21 The Cleveland Clinic Foundation Method for fixing tissue
WO2006102063A2 (en) 2005-03-19 2006-09-28 Cook Biotech Incorporated Prosthetic implants including ecm composite material
WO2006113382A2 (en) * 2005-04-15 2006-10-26 Wake Forest University Health Sciences Bioreactor system and method of enhancing functionality of muscle cultured in vitro
EP1719533A1 (en) * 2005-05-04 2006-11-08 Tecnobiomedica S.p.A. Method of preparing acellularized, biocompatible, implantable material
US9072816B2 (en) * 2006-01-18 2015-07-07 Cormatrix Cardiovascular, Inc. Composition for modulating inflammation of cardiovascular tissue
US8568761B2 (en) * 2005-07-15 2013-10-29 Cormatrix Cardiovascular, Inc. Compositions for regenerating defective or absent myocardium
EP2431063B1 (en) 2005-08-26 2015-06-17 Regents of the University of Minnesota Decellularization and recellularization of organs and tissues
AU2006311482B2 (en) * 2005-11-08 2011-08-25 Georgia Tech Research Corporation Acellularized biomaterial from embryonic stem cells
US20160082153A1 (en) * 2006-01-18 2016-03-24 Cormatrix Cardiovascular, Inc. Method and System for Treatment of Damaged Biological Tissue
GB0606231D0 (en) 2006-03-29 2006-05-10 Univ Leeds Improvements relating to decellurisation of tissue matrices for bladder implantation
AU2013203211B2 (en) * 2006-10-06 2015-05-28 Celularity Inc. Native (telopeptide) placental collagen compositions
EP2076279B1 (en) 2006-10-06 2014-08-27 Anthrogenesis Corporation Native (telopeptide) placental collagen compositions
CA2667214C (en) 2006-10-23 2015-12-01 Cook Biotech Incorporated Processed ecm materials with enhanced component profiles
CZ301086B6 (en) * 2007-10-17 2009-11-04 Bio-Skin, A. S. Sterile autogenous, allogenic or xenogenic implant and process for preparing thereof
US10413636B2 (en) 2008-08-14 2019-09-17 Kci Licensing, Inc. Tissue scaffolds
WO2012005760A1 (en) * 2010-06-30 2012-01-12 Miromatrix Medical Inc. Use of perfusion decellularized organs for matched recellularization
ES2562707T3 (en) 2010-09-01 2016-03-07 Regents Of The University Of Minnesota Methods of recelularization of a tissue or organ for a better transplant capacity
ES2724587T3 (en) 2011-01-06 2019-09-12 Humacyte Inc Constructs generated by tissue engineering
US20130013083A1 (en) * 2011-01-06 2013-01-10 Humacyte Tissue-Engineered Constructs
EP2714111B1 (en) 2011-05-31 2021-03-17 LifeCell Corporation Adipose tissue matrices
CN104053992B (en) * 2012-01-16 2016-12-14 皇家飞利浦有限公司 Determining the presence of target molecules in bodily fluids including cells
EP2822610B1 (en) 2012-03-08 2018-12-26 LifeCell Corporation Enzyme-activated collagen and tissue matrices
US9290738B2 (en) 2012-06-13 2016-03-22 Miromatrix Medical Inc. Methods of decellularizing bone
ES2676043T3 (en) 2012-07-05 2018-07-16 Lifecell Corporation Tissue Drainage Collectors
CN103536967B (en) * 2012-07-10 2016-04-13 上海微创医疗器械（集团）有限公司 A kind of method for removing cells preparing extracellular matrix support material
CA2878446A1 (en) 2012-07-13 2014-01-16 Lifecell Corporation Methods for improved treatment of adipose tissue
EP3332816B1 (en) 2012-09-26 2020-11-04 LifeCell Corporation Processed adipose tissue
WO2014110586A1 (en) * 2013-01-14 2014-07-17 Florida State University Research Foundation, Inc. Extracellular matrix derived from stem cells and methods for production
CN105164250A (en) 2013-03-15 2015-12-16 米罗马特里克斯医疗公司 Use of Perfused Decellularized Liver for Recellularization of Islet Cells
CN104353115B (en) * 2014-10-29 2016-06-01 南通大学附属医院 Take off the test kit of cytoskeleton, the preparation of support for pancreas and plant method for planting again
CN105013014A (en) * 2015-07-31 2015-11-04 武汉蓝普医品有限公司 Preparation method and application of acellular matrix biological material
CN105920670A (en) * 2016-05-19 2016-09-07 李世荣 Degradable male genital organ patch composite material with biological elasticity and preparation method thereof
CA3027505A1 (en) 2016-06-15 2017-12-21 The General Hospital Corporation Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions
ES2841427T3 (en) 2016-07-05 2021-07-08 Lifecell Corp Tissue matrices incorporating multiple tissue types
WO2018048899A1 (en) 2016-09-06 2018-03-15 Micromatrix Medical Inc. Use of resected liver serum for whole liver engineering
KR20250007698A (en) * 2017-05-30 2025-01-14 가부시키가이샤 아데카 Method for producing decellularized material for transplantation and graft composition comprising biocompatible material including said material
CN107596446B (en) * 2017-09-16 2020-07-28 温州医科大学 Decellularization kit for maintaining tissue ultrastructure and nutrition microenvironment
US11123375B2 (en) 2017-10-18 2021-09-21 Lifecell Corporation Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
EP3697460A1 (en) 2017-10-18 2020-08-26 LifeCell Corporation Adipose tissue products and methods of production
US11246994B2 (en) 2017-10-19 2022-02-15 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand
EP4309686A3 (en) 2017-10-19 2024-02-07 LifeCell Corporation Flowable acellular tissue matrix products and methods of production
US12263275B2 (en) 2018-06-13 2025-04-01 Miromatrix Medical Inc. Fistula filler and deployment system
CN110876816A (en) * 2018-09-06 2020-03-13 韩嫣 Pig bladder source bioactive repair material
AU2020283895A1 (en) 2019-05-30 2022-01-06 Lifecell Corporation Biologic breast implant
CN111569151B (en) * 2020-05-12 2021-12-17 上海亚朋生物技术有限公司 Acellular dermal matrix tissue engineering scaffold and preparation method thereof
CN111938885A (en) * 2020-08-25 2020-11-17 北京佰仁医疗科技股份有限公司 A kind of artificial biological bile duct and its preparation method and application
US12383657B1 (en) 2021-06-09 2025-08-12 Reprise Biomedical, Inc. Biologic matrix for a wound site and related methods
US11998662B1 (en) 2021-06-09 2024-06-04 Reprise Biomedical, Inc. Biologic matrix for a wound site and related methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8618374D0 (en) * 1986-07-28 1986-09-03 Hsc Res Dev Corp Biological vascular prostheses
US5735902A (en) * 1987-07-20 1998-04-07 Regen Biologics, Inc. Hand implant device
US5681353A (en) * 1987-07-20 1997-10-28 Regen Biologics, Inc. Meniscal augmentation device
CA2101557A1 (en) * 1991-02-14 1992-08-15 Roger Tu Pliable biological graft materials and their methods of manufacture
AU5564996A (en) * 1995-04-19 1996-11-07 St. Jude Medical Inc. Matrix substrate for a viable body tissue-derived prosthesis and method for making the same
US6376244B1 (en) * 1999-12-29 2002-04-23 Children's Medical Center Corporation Methods and compositions for organ decellularization

Also Published As

Publication number Publication date
AU2002224003A1 (en) 2002-05-27
WO2002040630A2 (en) 2002-05-23
WO2002040630A3 (en) 2004-06-10

Similar Documents

Publication Publication Date Title
IL139708A0 (en) Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering
AU8657601A (en) Composition and method for treatment of hypertriglyceridemia
PT1231887E (en) Method and composition for the treatment of scars
IL200540A (en) Tissue matrices comprising placental stem cells and methods of making them
EP1343726A4 (en) Processes and compositions for water treatment
EP1416044A4 (en) Support for cell / tissue culture and culture method
MXPA02001613A (en) Tissue augmentation material and methods.
AP2001002305A0 (en) Improved prosthesis and method thereof
AU7311501A (en) Cosmetic composition and method
ZA989694B (en) Shaped bodies for use as implants in human medicine and method for the production of such shaped bodies
IL153687A0 (en) Composition and method for enhancing elasticity of tissue
GB2359021B (en) Method and composition for promoting hair growth
IL130968A0 (en) Pharmaceutical composition useful for the treatment of tinnitus and hearing loss
GB2369675B (en) Method of treating biological specimens
GB2368397B (en) Method of treating biological specimens
AU5577101A (en) Enzymes useful for treating and methods for treating mps-vi and cells lines for producing such enzymes recombinantly
AU6137801A (en) Method and composition for the treatment of angiogenesis
AU2002337983A1 (en) Composition and method for treating erectile dysfunction and reducing fibrosis in erectile tissue of the human penis
GB2370115B (en) Method of treating biological specimens
GB2370635B (en) Method of treating biological specimens
AU5565401A (en) Materials and methods for the treatment of depression
PL361626A1 (en) Use, method and composition of organic acids in gypsum producing desulphurising plants
AU2034702A (en) Method of enhancing virus-resistance in plants and producing virus-immune plants
GB0229366D0 (en) Improvements in and relating to methods and apparatus for the application of honey to wounds
HUP0102002A3 (en) Biologically active composition and process for its preparation